XML 29 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 24, 2016
Sep. 26, 2015
Sep. 27, 2014
Operating activities:      
Net earnings $ 75,975,000 $ 70,183,000 $ 71,814,000
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation of fixed assets 34,536,000 32,356,000 31,660,000
Amortization of intangibles and deferred costs 5,587,000 5,915,000 5,433,000
Gains from disposals of property & equipment (398,000) (334,000) (119,000)
Amortization of bond premiums 1,011,000 103,000
Share-based compensation 2,375,000 2,166,000 2,076,000
Deferred income taxes 7,700,000 (121,000) (8,000)
Loss on sale of marketable securities 661,000 4,319,000 361,000
Changes in assets and liabilities, net of effects from purchase of companies:      
Decrease (increase) in accounts receivable, net 3,571,000 (3,123,000) (8,913,000)
Increase in inventories (6,295,000) (4,959,000) (1,857,000)
Increase in prepaid expenses and other (7,386,000) (2,871,000) (182,000)
Increase in accounts payable and accrued liabilities 3,888,000 287,000 6,831,000
Net cash provided by operating activities 121,225,000 103,921,000 107,096,000
Investing activities:      
Payments for purchases of companies, net of cash acquired (615,000) (28,360,000)
Purchases of property, plant and equipment (48,709,000) (48,641,000) (39,385,000)
Purchases of marketable securities (41,786,000) (90,240,000) (26,932,000)
Proceeds from Sale and Maturity of Marketable Securities 13,224,000 110,117,000 7,245,000
Proceeds from disposal of property, plant and equipment 2,294,000 1,786,000 1,572,000
Other 375,000 (898,000) (806,000)
Net cash used in investing activities (74,602,000) (28,491,000) (86,666,000)
Financing activities:      
Payments to repurchase common stock (15,265,000) (8,011,000) (7,505,000)
Proceeds from issuance of common stock 6,570,000 4,663,000 3,320,000
Payments on capitalized lease obligations (355,000) (243,000) (326,000)
Payment of cash dividend (28,523,000) (26,154,000) (20,924,000)
Net cash used in financing activities (37,573,000) (29,745,000) (25,435,000)
Effect of exchange rates on cash and cash equivalents (2,087,000) (3,756,000) (580,000)
Net increase (decrease) in cash and cash equivalents 6,963,000 41,929,000 (5,585,000)
Cash and cash equivalents at beginning of year 133,689,000 91,760,000 97,345,000
Cash and cash equivalents at end of year $ 140,652,000 $ 133,689,000 $ 91,760,000